Patent directory · USPTO A61K / A61P
Patents matching “Ionis Pharmaceuticals, Inc.”
202 pharma patents match "Ionis Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 202 pharmaceutical patents matching "Ionis Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12409188
Modulators of HSD17B13 expression
granted -
US 12410430
Modulating apolipoprotein (A) expression
granted -
US 12350285
Compounds and methods for reducing ATXN3 expression
granted -
US 12343357
Compositions and methods for modulating MECP2 expression
granted -
US 12297431
Modulation of huntingtin expression
granted -
US 12291709
Compositions and methods for modulating apolipoprotein (a) expression
granted -
US 12281305
Compounds and methods for reducing prion expression
granted -
US 12275940
Conjugated antisense compounds and their use
granted -
US 12241067
Compounds and methods for reducing LRRK2 expression
granted -
US 12227746
Compounds and methods for modulating SCN2A
granted -
US 12215321
Modulators of diacyglycerol acyltransferase 2 (DGAT2)
granted -
US 12188020
Methods for reducing Ataxin-2 expression
granted -
US 12180479
Compounds and methods for modulating ATXN1
granted -
US 12152244
Selective antisense compounds and uses thereof
granted -
US 12115225
GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof
granted -
US 12110491
Selective reduction of allelic variants
granted -
US 12043831
Modulation of alpha synuclein expression
granted -
US 12042510
Modulators of IRF4 expression
granted -
US 12030910
Compounds and methods for the modulation of proteins
granted -
US 12018261
Compounds and methods for modulating factor XII
granted -
US 11981897
Compounds and methods for modulation of dystrophia myotonica-protein kinase (DMPK) expression
granted -
US 11959080
Methods and compositions for inhibiting PMP22 expression
granted -
US 11926825
Compounds and methods for reducing ATXN2 expression
granted -
US 11926830
Modulators of Complement Factor B
granted